NeoPharm CO. LTD Cash Flow Reinvestment Rate

Latest as of September 2025: 0.25x

NeoPharm CO. LTD cash flow reinvestment rate. NeoPharm CO. LTD (092730) has a Cash Flow Reinvestment Rate of 0.25x as of September 2025, reinvesting ₩1.45 Billion (capex ₩446.60 Million plus investments ₩-1.00 Billion) from operating cash flow of ₩5.88 Billion. Explore NeoPharm CO. LTD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.25x
(Capex + Investments) / Operating CF

Total Reinvested

₩1.45 Billion
Capex + Investments

Operating Cash Flow

₩5.88 Billion
KRW

Capital Expenditures

₩446.60 Million
KRW

Cash Flow Reinvestment Rate of NeoPharm CO. LTD (2012–2024)

Cash flow reinvestment rate of NeoPharm CO. LTD from 2012 to 2024. Historical reinvestment intensity for NeoPharm CO. LTD across 11 annual periods. Explore 092730 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

NeoPharm CO. LTD Cash Flow Reinvestment Rate by Year (2012–2024)

NeoPharm CO. LTD cash flow reinvestment rate by year from 2012 to 2024. Year-by-year capital reinvestment analysis for NeoPharm CO. LTD. For the full cash flow conversion analysis, see 092730 cash generation efficiency.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.50x ₩9.30 Billion ₩18.63 Billion ₩3.08 Billion ▼ -68.8%
2023 1.60x ₩37.18 Billion ₩23.26 Billion ₩20.83 Billion ▲ +202.2%
2022 0.53x ₩9.61 Billion ₩18.16 Billion ₩806.43 Million ▼ -29.7%
2021 0.75x ₩16.32 Billion ₩21.68 Billion ₩320.11 Million ▲ +199.9%
2020 0.25x ₩4.29 Billion ₩17.07 Billion ₩285.62 Million ▼ -90.7%
2019 2.70x ₩51.90 Billion ₩19.22 Billion ₩5.90 Billion ▲ +398.5%
2018 0.54x ₩8.76 Billion ₩16.18 Billion ₩1.94 Billion ▼ -48.2%
2017 1.05x ₩11.13 Billion ₩10.65 Billion ₩884.71 Million ▲ +17.2%
2016 0.89x ₩8.17 Billion ₩9.16 Billion ₩1.40 Billion ▲ +133.3%
2015 0.38x ₩2.33 Billion ₩6.09 Billion ₩786.89 Million ▼ -81.5%
2012 2.06x ₩1.16 Billion ₩564.34 Million ₩172.47 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow